Jose Gonzalez-Castano Jose Lopez-Barneo (MD PhD, Medical Facul Pablo Martinez-Martin
Affecting over 1.5 million people across the world, Parkinson's disease is a progressive neurological condition characterized, in part, by the loss of dopaminergic neurons in the substantia nigra pars compacta. It affects 1.5% of the global population over 65 years of age. As life expectancy is increasing, over the next few years the number of patients with Parkinsons disease will grow exponentially. To date, there are no available treatments that are capable of curing Parkinsons disease, and the current goal of therapy, dopamine replacement strategies, is to reduce symptoms. After several...
Affecting over 1.5 million people across the world, Parkinson's disease is a progressive neurological condition characterized, in part, by the loss...